Cargando…
Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial
BACKGROUND: Dry eye disease (DED) is one of the most common complications following refractive surgery. PURPOSE: Evaluate the efficacy of an osmoprotective eye drop (Optive®) for the management of induced DED in refractive surgery patients. DESIGN: Double-masked randomised controlled trial. METHODS:...
Autores principales: | Hazarbassanov, R. M., Queiroz-Hazarbassanov, N. G. T., Barros, J. N., Gomes, J. A. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838485/ https://www.ncbi.nlm.nih.gov/pubmed/29675272 http://dx.doi.org/10.1155/2018/4324590 |
Ejemplares similares
-
Calculation of Unknown Preoperative K Readings in Postrefractive Surgery Patients
por: Rosa, Nicola, et al.
Publicado: (2018) -
Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017) -
Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
por: Mullick, Ritika, et al.
Publicado: (2021) -
Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease
por: Mateo Orobia, Antonio José, et al.
Publicado: (2018) -
Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)